Sulfadiazine Sodium

磺胺嘧啶钠

Report date: 2022/09/22 10:59:51

Base Information

Drug NameSulfadiazine Sodium
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydropteroate synthase inhibitors
TargetsDihydropteroate synthase
Therapy Area/IndicationsMeningococcal Infections
Global Approved IndicationsMeningococcal Infections
Approved Indications in ChinaMeningococcal Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesYichang Humanwell Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMeningococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG